Nurse Practitioner, Family · Appleton, WI
NPI
1063044782
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1506 S Oneida St
Appleton, WI, 54915
Phone (920) 730-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
160 services
Medicare patients, 2024
133
Average age 71
Drug cost, 2024
$534K
1,533 prescriptions
Company payments, 2025
$153
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca A Kloehn was code 99214 (office e&m - established), 141 times for 119 patients. In total Rebecca A Kloehn billed 160 services in 5 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 141 | 119 | $71.16 | $10K |
| 99204 Office E&M - New | Office | 15 | 15 | $94.18 | $1,413 |
By year: 2022 $11K for 134 services; 2023 $11K for 139 services; 2024 $12K for 160 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca A Kloehn prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 252 prescriptions and refills. In total Rebecca A Kloehn wrote 1,533 Medicare prescriptions that cost $534K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 252 | 326 | 48 | $203K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 250 | 268 | 96 | $7,855 |
| Montelukast Sodium Generic | 124 | 250 | 28 | $982 |
| Breo Ellipta Fluticasone/Vilanterol | 84 | 102 | 19 | $40K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 76 | 102 | 16 | $47K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 69 | 110 | 17 | $15K |
| Symbicort Budesonide/Formoterol Fumarate | 58 | 90 | 17 | $20K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 48 | 66 | 13 | $13K |
| Breyna Budesonide/Formoterol Fumarate | 47 | 53 | 12 | $10K |
| Spiriva Respimat Tiotropium Bromide | 45 | 57 | 13 | $30K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 44 | 60 | Under 11 | $28K |
| Azithromycin Generic | 42 | 50 | Under 11 | $419 |
| Fluticasone-Vilanterol Fluticasone/Vilanterol | 41 | 73 | 13 | $23K |
| Arnuity Ellipta Fluticasone Furoate | 34 | 44 | Under 11 | $8,987 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 26 | 34 | Under 11 | $3,072 |
Brand drugs: 1,075 claims; generic drugs: 458 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca A Kloehn $153 ($153 in general payments such as food, travel and fees) from 2 companies. The largest payer was Verona Pharma, Inc. with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.